As unbelievable as it sounds in 2018, despite being preventable and curable Tuberculosis (TB) is on the rise in New York City for the first time in 25 years. Cases of drug-resistant TB, which are much more difficult and costly…
By Suraj Madoori During Trump’s first-ever State of the Union address on January 30, activists observed a dearth of clear priorities to eliminate HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV) in the U.S. Science and longstanding bipartisan interest in…
Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant…
August 23, 2019 –This guide is for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them. It explains what global standards are for TB prevention, treatment, and care, so…
Good COPs or Bad COPs: Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs). Every year, PEPFAR meets to discuss their strategy and budget for the following year, and set targets on implementing country operation…
January 10, 2018 – The Tuberculosis Trials Consortium (TBTC) is a global leader in research and development for better tools to prevent, diagnose, and treat tuberculosis (TB). Housed within the U.S. Centers for Disease Control and Prevention (CDC), the TBTC conducts clinical…
Note that the following PDFs listed at the top of this page were handouts shared with the Webinar: --Phase III Clinical Trial Results at the 48th Union World Conference on Lung Health: Implications for the Field1, PDF --TB CAB's Proposed…
On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health. Introduction -…